 MALVERN, Pa., Dec. 18, 2020 GLOBE NEWSWIRE -- Recro Nasdaq:REPH, a leading contract development and manufacturing organization CDMO, with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products, today announced that it granted an inducement award to its newly-appointed President and Chief Executive Officer, David Enloe. 